Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.
B S Coller, … , G S Rudomen, K T Springer
B S Coller, … , G S Rudomen, K T Springer
Published December 1, 1993
Citation Information: J Clin Invest. 1993;92(6):2796-2806. https://doi.org/10.1172/JCI116899.
View: Text | PDF
Research Article Article has an altmetric score of 3

Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.

  • Text
  • PDF
Abstract

The accessibility of activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to damaged blood vessels or atherosclerotic plaques is likely to play a crucial role in subsequent platelet recruitment. To define better the factors involved in this process, we developed a functional assay to assess the presence of activated, luminal GPIIb/IIIa receptors, based on their ability to bind erythrocytes containing a high density of covalently coupled RGD-containing peptides (thromboerythrocytes). Platelets readily adhered to wells coated with purified type I rat skin collagen and the adherent platelets bound a dense lawn of thromboerythrocytes. With fibrinogen-coated wells, platelet adhesion increased as the fibrinogen-coating concentration increased, reaching a plateau at about 11 micrograms/ml. Thromboerythrocyte binding to the platelets adherent to fibrinogen showed a paradoxical response, increasing at fibrinogen coating concentrations up to approximately 4-6 micrograms/ml and then dramatically decreasing at higher fibrinogen-coating concentrations. Scanning electron microscopy demonstrated that the morphology of platelets adherent to collagen was similar to that of platelets adherent to low density fibrinogen, with extensive filopodia formation and ruffling. In contrast, platelets adherent to high density fibrinogen showed a bland, flattened appearance. Immunogold staining of GPIIb/IIIa receptors demonstrated concentration of the receptors on the filopodia, and depletion of receptors on the flattened portion of the platelets. Thus, there is a paradoxical loss of accessible, activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to high density fibrinogen. Two factors may contribute to this result: engagement of GPIIb/IIIa receptors with fibrinogen on the abluminal surface leading to the loss of luminal receptors, and loss of luminal filopodia that interact with thromboerythrocytes. These data provide insight into the differences in thrombogenicity between surfaces, and may provide a mechanism for purposefully passivating platelet-reactive artificial surfaces.

Authors

B S Coller, J L Kutok, L E Scudder, D K Galanakis, S M West, G S Rudomen, K T Springer

×

Total citations by year

Year: 2019 2015 2013 2011 2010 2009 2007 2005 2004 2001 1999 1998 1997 1996 1995 1994 Total
Citations: 1 1 2 2 1 1 1 1 1 2 2 1 1 1 1 2 21
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (21)

Title and authors Publication Year
Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen
AC Brown, E Lavik, SE Stabenfeldt
Bioconjugate Chemistry 2019
Synthetic Strategies for Engineering Intravenous Hemostats
LW Chan, NJ White, SH Pun
Bioconjugate Chemistry 2015
Tuning Ligand Density on Intravenous Hemostatic Nanoparticles Dramatically Increases Survival Following Blunt Trauma
AJ Shoffstall, LM Everhart, ME Varley, ES Soehnlen, AM Shick, JS Ustin, EB Lavik
Biomacromolecules 2013
Swing-Out of the β3 Hybrid Domain Is Required for αIIbβ3 Priming and Normal Cytoskeletal Reorganization, but Not Adhesion to Immobilized Fibrinogen
M Cheng, J Li, A Negri, BS Coller, LR Languino
PloS one 2013
Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells
Z Fulkerson, T Wu, M Sunkara, CV Kooi, AJ Morris, SS Smyth
The Journal of biological chemistry 2011
Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis
S Absar, S Choi, VC Yang, YM Kwon
Journal of Controlled Release 2011
Acute coronary syndromes: assessing risk and choosing optimal pharmacological regimens for a superior outcome
N Uren
European Heart Journal Supplements 2010
Corrosion behavior and fibrinogen adsorptive interaction of SS316L surfaces covered with ethylene glycol plasma polymer-coated Ti nanoparticles
J Tavares, A Shahryari, J Harvey, S Coulombe, S Omanovic
Surface and Coatings Technology 2009
Ligand density dramatically affects integrin αIIbβ3-mediated platelet signaling and spreading
M Jiroušková, JK Jaiswal, BS Coller
Blood 2007
Fibrin but Not Adsorbed Fibrinogen Supports Fibronectin Assembly by Spread Platelets: EFFECTS OF THE INTERACTION OF αIIbβ3 WITH THE C TERMINUS OF THE FIBRINOGEN γ-CHAIN
J Cho, JL Degen, BS Coller, DF Mosher
The Journal of biological chemistry 2005
New horizons in the analysis of circulating cell-derived microparticles
LL Horstman, W Jy, JJ Jimenez, C Bidot, YS Ahn
The Keio Journal of Medicine 2004
Reactivity of Human Platelets With Immobilized Fibrinogen is Dictated by the Chemical Character of the Surface
BC Cook
Thrombosis Research 2001
Procoagulant Activity on Platelets Adhered to Collagen or Plasma Clot
S Ilveskero, P Siljander, R Lassila
Arteriosclerosis, thrombosis, and vascular biology 2001
Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both alpha2beta1 integrin and GP VI
T Nakamura, J Kambayashi, M Okuma, NN Tandon
The Journal of biological chemistry 1999
PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells
K Cichowski, M J Orsini, L F Brass
Biochimica et Biophysica Acta 1999
Peptide LSARLAF Activates αIIbβ3 on Resting Platelets and Causes Resting Platelet Aggregate Formation Without Platelet Shape Change
JM Derrick, RG Loudon, TK Gartner
Thrombosis Research 1998
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics
BS Coller
Journal of Clinical Investigation 1997
Immunocytochemical Aspects of Platelet Membrane Glycoproteins and Adhesive Proteins During Activation
H Suzuki, H Yamazaki, K Tanoue
Progress in Histochemistry and Cytochemistry 1996
Platelet transfusion and alternatives to transfusion in patients with malignancy
L Vaickus, JB Breitmeyer, RL Schlossmann, KC Anderson
Stem Cells 1995
Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months
EJ Topol, RM Califf, HF Weisman, SG Ellis, JE Tcheng, S Worley, R Ivanhoe, BS George, D Fintel, M Weston, K Sigmon, KM Anderson, KL Lee, JT Willerson
The Lancet 1994
Fibronectin inhibition of platelet thrombus formation in an in vivo porcine model of vascular injury
DG Moon, BM Matayoshi, LK Weston, FL Minnear, JE Kaplan
Thrombosis Research 1994

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
20 readers on Mendeley
See more details